What is she best known for?
The fields of study she is best known for:
- Immune system
- Virus
- Internal medicine
Her primary areas of investigation include Immunology, Cytotoxic T cell, Hepatitis B virus, Interleukin 21 and Antigen.
Her work on Immune system, Interferon gamma and Leishmaniasis as part of general Immunology research is frequently linked to Liposome, thereby connecting diverse disciplines of science.
Her Cytotoxic T cell study integrates concerns from other disciplines, such as Interleukin 2, T cell, T-cell receptor and CD8.
She focuses mostly in the field of Hepatitis B virus, narrowing it down to topics relating to Hepatitis B and, in certain cases, Regulatory B cells.
As a member of one scientific family, she mostly works in the field of Antigen, focusing on Viral load and, on occasion, CTLA-4, T lymphocyte, Avidity and Immune tolerance.
Mala K. Maini studies Virus, a branch of Virology.
Her most cited work include:
- The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. (664 citations)
- Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms (352 citations)
- Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage (336 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Immunology, Virology, Cytotoxic T cell, Immune system and CD8.
Immunology is represented through her Hepatitis B virus, Virus, T cell, Hepatitis B and Chronic hepatitis research.
Her studies deal with areas such as Interferon and Viral load as well as Hepatitis B virus.
Her Virology study incorporates themes from Antigen presentation and Antigen.
Her research links Epitope with Cytotoxic T cell.
Her CD8 research is multidisciplinary, incorporating elements of Molecular biology and Human leukocyte antigen.
She most often published in these fields:
- Immunology (63.45%)
- Virology (34.52%)
- Cytotoxic T cell (32.49%)
What were the highlights of her more recent work (between 2017-2021)?
- Immunology (63.45%)
- T cell (20.81%)
- Antigen (19.29%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Immunology, T cell, Antigen, CD8 and Virology.
Her research on Immunology often connects related topics like Prospective cohort study.
Her studies in T cell integrate themes in fields like Cell, In vitro, Hepatitis b surface antigen and Cell biology.
Her work deals with themes such as Cytotoxic T cell, Molecular biology and Immunotherapy, which intersect with CD8.
Mala K. Maini interconnects Pathology, Cytotoxicity, Transplantation and Hepatitis B virus in the investigation of issues within Cytotoxic T cell.
Her study in the field of Virus and Anti hbs antibody is also linked to topics like Prime boost vaccination.
Between 2017 and 2021, her most popular works were:
- A global scientific strategy to cure hepatitis B (119 citations)
- Circulating and intrahepatic antiviral B cells are defective in hepatitis B (87 citations)
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Internal medicine
- Virus
Her primary scientific interests are in CD8, Hepatitis B virus, Hepatitis B, Immunity and T cell.
Her work on HBsAg as part of general Hepatitis B virus study is frequently linked to Liver biopsy, therefore connecting diverse disciplines of science.
Mala K. Maini works mostly in the field of Hepatitis B, limiting it down to topics relating to Virus and, in certain cases, Hepatic fibrosis, Bioinformatics and Disease.
Her Immunity research is within the category of Immunology.
Her research brings together the fields of Epigenetics and Immunology.
Her T cell research integrates issues from Cytokine, Downregulation and upregulation, Antigen and Cytotoxic T cell, Interleukin 15.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
